Cargando…

Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis

Systemic vasculitis are multisystem blood vessel disorders. However, Portal venous involvement is extremely rare, which represents a diagnostic and therapeutic challenge due to the heterogeneous nature, a lack of diagnostic criteria and limited effective therapy of vasculitis. We have reported a 48-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Qiuyu, Wei, Bo, Tai, Yang, Wu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596301/
https://www.ncbi.nlm.nih.gov/pubmed/36311772
http://dx.doi.org/10.3389/fimmu.2022.1005300
_version_ 1784815840067059712
author Cai, Qiuyu
Wei, Bo
Tai, Yang
Wu, Hao
author_facet Cai, Qiuyu
Wei, Bo
Tai, Yang
Wu, Hao
author_sort Cai, Qiuyu
collection PubMed
description Systemic vasculitis are multisystem blood vessel disorders. However, Portal venous involvement is extremely rare, which represents a diagnostic and therapeutic challenge due to the heterogeneous nature, a lack of diagnostic criteria and limited effective therapy of vasculitis. We have reported a 48-year-old woman who was previously diagnosed with systemic vasculitis and was treated with prednisone, presented with gastrointestinal (GI) bleeding on admission. Further abdominal contrast-enhanced computed tomography (CT) with three-dimensional reconstruction suggested atrophic left hepatic lobe, enlarged spleen, and severe stenosis of main portal vein. Liver biopsy showed no evidence of fibrosis/cirrhosis. To prevent rebleeding, portal venous angioplasty by balloon dilation with collateral varices embolization was performed, and the GI hemorrhage was resolved completely. However, refractory ascites presented 8 months postoperatively. Abdominal CT angiography confirmed the recurrence of portal venous stenosis. Portal venous angioplasty by stent implantation was then performed to treat the portal hypertension (PHT)-related complications. After the intervention, the patient received anticoagulation therapy and continued immunosuppressive therapy. During the 5-year follow-up, the patient did not experience any onset of GI bleeding or ascites. Therefore, portal venous angioplasty with stent placement could be an effective treatment to prevent PHT-related complications when immunosuppression therapy failed.
format Online
Article
Text
id pubmed-9596301
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95963012022-10-27 Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis Cai, Qiuyu Wei, Bo Tai, Yang Wu, Hao Front Immunol Immunology Systemic vasculitis are multisystem blood vessel disorders. However, Portal venous involvement is extremely rare, which represents a diagnostic and therapeutic challenge due to the heterogeneous nature, a lack of diagnostic criteria and limited effective therapy of vasculitis. We have reported a 48-year-old woman who was previously diagnosed with systemic vasculitis and was treated with prednisone, presented with gastrointestinal (GI) bleeding on admission. Further abdominal contrast-enhanced computed tomography (CT) with three-dimensional reconstruction suggested atrophic left hepatic lobe, enlarged spleen, and severe stenosis of main portal vein. Liver biopsy showed no evidence of fibrosis/cirrhosis. To prevent rebleeding, portal venous angioplasty by balloon dilation with collateral varices embolization was performed, and the GI hemorrhage was resolved completely. However, refractory ascites presented 8 months postoperatively. Abdominal CT angiography confirmed the recurrence of portal venous stenosis. Portal venous angioplasty by stent implantation was then performed to treat the portal hypertension (PHT)-related complications. After the intervention, the patient received anticoagulation therapy and continued immunosuppressive therapy. During the 5-year follow-up, the patient did not experience any onset of GI bleeding or ascites. Therefore, portal venous angioplasty with stent placement could be an effective treatment to prevent PHT-related complications when immunosuppression therapy failed. Frontiers Media S.A. 2022-10-12 /pmc/articles/PMC9596301/ /pubmed/36311772 http://dx.doi.org/10.3389/fimmu.2022.1005300 Text en Copyright © 2022 Cai, Wei, Tai and Wu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Cai, Qiuyu
Wei, Bo
Tai, Yang
Wu, Hao
Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis
title Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis
title_full Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis
title_fullStr Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis
title_full_unstemmed Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis
title_short Case Report: Interventional therapy for portal venous stenosis caused by systemic vasculitis
title_sort case report: interventional therapy for portal venous stenosis caused by systemic vasculitis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596301/
https://www.ncbi.nlm.nih.gov/pubmed/36311772
http://dx.doi.org/10.3389/fimmu.2022.1005300
work_keys_str_mv AT caiqiuyu casereportinterventionaltherapyforportalvenousstenosiscausedbysystemicvasculitis
AT weibo casereportinterventionaltherapyforportalvenousstenosiscausedbysystemicvasculitis
AT taiyang casereportinterventionaltherapyforportalvenousstenosiscausedbysystemicvasculitis
AT wuhao casereportinterventionaltherapyforportalvenousstenosiscausedbysystemicvasculitis